About 528,000 results
FDA Update: Sotagliflozin Approved For Broad HF Treatment
SGLT2 inhibitor empagliflozin is shown to be safe and effective for ...
KDIGO provided recommendations on SGLT2 inhibitors and …
FDA approves first SGLT1/SGLT2 inhibitor for heart failure
SGLT2 inhibitors in CKD and HFpEF: two new large trials and two …
SGLT2 inhibitors and GLP-1 receptor agonists: established and …
SGLT2 inhibitors as the bedrock of therapy for heart failure
SGLT2 inhibitors: role in protective reprogramming of cardiac
FDA Approves SGLT2 Inhibitor STEGLATRO™ (ertugliflozin) and ... - Pfizer
Applications of SGLT2 inhibitors beyond glycaemic control
- Some results have been removed